Wednesday, July 27, 2011

白癜风(vitiliginous Complexion)


春秋战国时代中庸医学程之为【白驳风】或【白斑纹】或【斑白】等古名。属于体内运作障碍之因素,导致自然色素脱失而肌损处出现白斑色或乳白色斑之一种肤颜病。

它不直接影响健康惟有碍美观。

此病开始喜发於夏季,盛於冬季,青年男女性多见,中年晚年少有。可单发或泛发,呈对称或不对称出现,形状不定,大小不一,日嗮后可以减轻或无意中通过饮食,机体获得所需之营卫而自然消失。病发速度缓慢,若经年累月不治,机体更虚损时情况会加重难愈而令患者精神紧张,烦恼及痛苦。

白癜风的病因病理:

本病的外因是感受风邪或跌伤,内因是情志所伤,血虚失精导致气血失和,肝肾不足和血瘀阻络而生白癜风。

(一) 气血不和

情志内伤,气血违和,肌表组织失养而抗卫之能甚缺时,风邪易x客於肌表,经络脉受阻而生白癜风。

(二) 肝肾不足

先天素体欠健,肝主藏血,肾主藏精,肝肾亏虚,精亏不能化血,血虚有无以生精,长期精气不足,机体就虚失养导致精失,机表皮毛失荣卫之养而生白癜风。

(三) 血瘀阻络

跌伤损肌,或怒伤肝胆而气滞血瘀导致血瘀阻络。络脉受阻,瘀血不消,新血不生,气血运行失常,体肤失其荣养泽悦而生白癜风。

本病的肌损会呈白色或乳白色斑点或斑片,逐渐扩大,边缘或有深褐色或中央有褐色斑点。常出现在指背,手腕,前手臂,肘部耳环,左右面额,眼睛周围,颈项,发际,胸,腹,前阴,后阴,腰背。白癜风斑内的毛也会变白但是无痒或麻木之感觉,也无脱屑。

 必须考虑肌损的情况和肌体症状以及舌与脉来调养:

(一)气血不和症状:

发病的时间长短不一,多在三个月到十八个月左右,无意中发现肌损外呈圆圈形或椭圆形或不规则的片状分佈。发病之前,患者会感觉体质较平常虚弱,或有经神刺激,可伴有四肢酸软,出汗恶风等症状。舌色淡红,苔白,脉滑细无力。

郭生草药健脾益胃,养育气血,通络消风调养方法:

用002,113,7,,HNIII,168,001各八药匙。一日两次辰时和酉时空腹吃。

(二)肝肾不足症状:

若是肝肾不足而引发本病则发病的时间比较长,可伴有家族病史,白癜风局限在一处而不扩大伸展,斑色是纯白色,斑内毛发也属白。境界整齐边缘清楚,可伴有腰膝酸软,遗精盗汗,双眼干燥少泪水,伴有头眩耳鸣等症状。舌淡红无华或舌质干红少苔。因为肾藏精,其华在发;肝藏血,其华在爪,发为血之馀,所以肝肾不足,毛发可随白癜风变白;体质失养故斑色纯白。肾精亏损,腰腑失养故腰膝酸软,骨蒸盗汗;肝血不足,头目失养则有双目干涩及头眩耳鸣之症状。

郭生草药滋补肝肾,养血祛风,清热滋阴止骨蒸盗汗调养方法:

用草药1688,HNI,88,HNIII,313,7,001,16,106,23,168各八药匙。一日两次辰时和酉时空腹吃。

(三)血瘀阻络症状:

此症病程长久,白癜风局限在一处或泛发全身,正常肌色不多。肌损呈地图形或斑块形,境界清楚易辨,边缘呈深褐色或紫褐色。伴有口唇呈紫色,面色青白,口干不欲饮之症状。舌质暗有瘀点或瘀斑。脉象涩滞。

血瘀阻络,瘀血不去,新血不生,肌肤失养故生白癜风斑。

郭生草药活血化瘀,疏通经络,养新血除斑调养方法:

用草药168,001,7,113,002,23,106,HNIII各八药匙。一日两次辰时和酉时空腹吃。

Sunday, July 10, 2011

Colon and Rectum Cancer

It is estimated that 142,570 men and women (72,090 men and 70,480 women) will be diagnosed with and 51,370 men and women will die of cancer of the colon and rectum in 20101.


The following information is based on NCI’s SEER Cancer Statistics Review2.Use the links on this page to learn more about each statistic type:
  1. Incidence & Mortality
  2. Survival & Stage
  3. Lifetime Risk
  4. Prevalence
Incidence & Mortality


SEER Incidence
 From 2004-2008, the median age at diagnosis for cancer of the colon and rectum was 70 years of age3. Approximately 0.1% were diagnosed under age 20; 1.1% between 20 and 34; 3.9% between 35 and 44; 12.8% between 45 and 54; 19.6% between 55 and 64; 24.1% between 65 and 74; 26.2% between 75 and 84; and 12.2% 85+ years of age.


The age-adjusted incidence rate was 47.2 per 100,000 men and women per year. These rates are based on cases diagnosed in 2004-2008 from 17 SEER geographic areas.


US Mortality


From 2003-2007, the median age at death for cancer of the colon and rectum was 75 years of age4. Approximately 0.0% died under age 20; 0.6% between 20 and 34; 2.4% between 35 and 44; 8.1% between 45 and 54; 15.6% between 55 and 64; 22.2% between 65 and 74; 30.4% between 75 and 84; and 20.6% 85+ years of age.


The age-adjusted death rate was 17.6 per 100,000 men and women per year. These rates are based on patients who died in 2003-2007 in the US.


Trends in Rates


Trends in rates can be described in many ways. Information for trends over a fixed period of time, for example 1996-2008, can be evaluated by the annual percentage change (APC) (See Fast Stats for trends over fixed time intervals) . If there is a negative sign before the number, the trend is a decrease; otherwise it is an increase. If there is an asterisk after the APC then the trend was significant, that is, one believes that it is beyond chance, i.e. 95% sure, that the increase or decrease is real over the period 1996-2008. If the trend is not significant, the trend is usually reported as stable or level. Joinpoint analyses can be used over a long period of time to evaluate when changes in the trend have occurred along with the APC which shows how much the trend has changed between each of the joinpoints.




Survival & Stage


Survival can be calculated by different methods for different purposes. The survival statistics presented here are based on relative survival, which measures the survival of the cancer patients in comparison to the general population to estimate the effect of cancer. The overall 5-year relative survival for 2001-2007 from 17 SEER geographic areas was 64.3%. Five-year relative survival by race and sex was: 65.5% for white men; 64.5% for white women; 55.0% for black men; 56.9% for black women.
The stage distribution is based on Summary Stage 2000. (See Fast Stats for more detailed statistics)


Lifetime Risk


Based on rates from 2005-2007, 5.12% of men and women born today will be diagnosed with cancer of the colon and rectum at some time during their lifetime. This number can also be expressed as 1 in 20 men and women will be diagnosed with cancer of the colon and rectum during their lifetime. These statistics are called the lifetime risk of developing cancer. Sometimes it is more useful to look at the probability of developing cancer of the colon and rectum between two age groups. For example, 2.04% of men will develop cancer of the colon and rectum between their 50th and 70th birthdays compared to 1.53% for women. (See Fast Stats for more detailed statistics, and Probability of Developing and Dying of Cancer for methodology)


Prevalence


On January 1, 2008, in the United States there were approximately 1,110,077 men and women alive who had a history of cancer of the colon and rectum -- 542,127 men and 567,950 women. This includes any person alive on January 1, 2008 who had been diagnosed with cancer of the colon and rectum at any point prior to January 1, 2008 and includes persons with active disease and those who are cured of their disease. Prevalence can also be expressed as a percentage and it can also be calculated for a specific amount of time prior to January 1, 2008 such as diagnosed within 5 years of January 1, 2008. (See Fast Stats for more detailed statistics, and Overview of Prevalence Statistics for methodology)